Health Protection and Multidisciplinary Public Health

Significant amounts of information and prior research is available, looking at the situation of mental health disorders within populations, and considering the most cost effective way for treatment.

In this evaluative report, the author aims to consider two of these studies. The first paper by Heller, Gemmell, and Patterson (2006) analyses four treatment methods provided within clinical guidelines, for effectiveness from the perspective of preventing further hospital readmissions and relapses for both depression and schizophrenia.

The second paper by Chen, Killeya-Jones, and Vega, (2005) considers the extent to which mental disorders exist within the United States (US)  adolescence, and the likelihood of any clusters of mental disorder co-occurring.

Helping to prioritise interventions for depression and schizophrenia: Use of Population Impact Measures. Clinical Practice and Epidemiology in Mental Health: (Heller, R; Gemmell, I; Patterson, L; 2006)

The paper by Heller, Gemmell and Patterson (2006), aimed to investigate the impact of implementing a ‘best practice’ approach on reducing the number of hospital admissions and relapses for patients suffering from both depression and schizophrenia. A ‘best practice’ approach can be defined by The National Institute of Clinical Excellence (NICE) as integrating “pharmacological agents…specific psychological interventions…[and]…service delivery systems…to provide [the] best…care of individuals with a diagnosis of [disorder]” (NICE Guidelines, 2007). The paper focuses on the impact and efficiency of a multiplicity of treatment methods observed over a one year period.

The number of events prevented in a population (NEPP) is calculated within the paper for a variety of treatments. These are anti-depressant therapy, screening, cognitive behaviour therapy (CBT), increased care management for depression, early intervention, adherence to medical advice, family intervention, and relapse prevention for schizophrenia.

Data for prevalence is derived from external publications, with central tendency measures installed for those with discrepancies.  Overall, the study found that the culmination of all treatments resulted in one hundred and nineteen cases of schizophrenia, and nine hundred and thirty one of depression did not experience relapse or hospital re-admission as a result of their treatment, although the significant factor here is the large disparity between the two disorders.

Whilst guidelines often give relevant information, the authors recognise these are limited when showing the potential benefit of each to the actual population. NICE guidelines on depression show that ‘recommendations for routine screening are frequently made without reference to empirical data’ (NICE Guidelines, 2007: 74) however, do not show the benefits of such screenings. Therefore, the study aims to ‘plug this research gap’. Similarly, on Schizophrenia, NICE recognises that ‘Oral atypical antipsychotic drugs’ (NICE Guidelines, 2007: 38) may be used as an initial treatment; however, this does not demonstrate the long term health effects of these drugs when treating the disorder within the general population.

Join now!

The results from the study are apparent and succinct, and are clearly separated into subsections, indicating that only 48% of those with depression are formally diagnosed, and that 50% of those experienced relapse. NEPP calculations from the studies data show that those receiving CBT as part of their treatment programme were least likely to experience relapse in the future. Powell et al. (2007: 74)  whose literature review found CBT to be ‘one of the therapeutic modalities’ with high empirical efficacy further support this finding.  Despite this, according to Heller et al., (2006) only 5% of patients received CBT as ...

This is a preview of the whole essay